Statement Of Cash Flows [Abstract]

Medicover - Filing #690784

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
EUR
EUR
EUR
140,000,000 EUR
121,000,000 EUR
19,000,000 EUR
EUR
121,000,000 EUR
EUR
EUR
EUR
48,000,000 EUR
EUR
EUR
EUR
EUR
1,018,000,000 EUR
EUR
EUR
EUR
1,066,000,000 EUR
1,018,000,000 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in inventories
127,000,000 EUR
171,000,000 EUR
Adjustments for unrealised foreign exchange losses (gains)
39,000,000 EUR
26,000,000 EUR
Adjustments for share-based payments
96,000,000 EUR
64,000,000 EUR
Other adjustments for non-cash items
22,000,000 EUR
18,000,000 EUR
Income taxes paid (refund), classified as operating activities
191,000,000 EUR
183,000,000 EUR
Cash flows from (used in) operating activities
1,702,000,000 EUR
2,167,000,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
2,291,000,000 EUR
875,000,000 EUR
Cash advances and loans made to other parties, classified as investing activities
0 EUR
28,000,000 EUR
Interest received, classified as investing activities
17,000,000 EUR
9,000,000 EUR
Other inflows (outflows) of cash, classified as investing activities
1,864,000,000 EUR
403,000,000 EUR
Cash flows from (used in) investing activities
1,848,000,000 EUR
3,336,000,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments from changes in ownership interests in subsidiaries that do not result in loss of control
77,000,000 EUR
15,000,000 EUR
Proceeds from issuing shares
EUR
3,000,000 EUR
Payments to acquire or redeem entity's shares
EUR
3,000,000 EUR
Proceeds from borrowings, classified as financing activities
5,241,000,000 EUR
2,937,000,000 EUR
Repayments of borrowings, classified as financing activities
4,347,000,000 EUR
547,000,000 EUR
Payments of lease liabilities, classified as financing activities
506,000,000 EUR
385,000,000 EUR
Dividends paid, classified as financing activities
178,000,000 EUR
104,000,000 EUR
Interest paid, classified as financing activities
324,000,000 EUR
197,000,000 EUR
Cash flows from (used in) financing activities
243,000,000 EUR
1,641,000,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
389,000,000 EUR
472,000,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
26,000,000 EUR
120,000,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
389,000,000 EUR
472,000,000 EUR
Cash and cash equivalents
404,000,000 EUR
819,000,000 EUR
467,000,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.